Conformationally rigid N-acyl-5-alkyl- l-prolyl-pyrrolidines as prolyl oligopeptidase inhibitors

In the N-acyl- l-prolyl-pyrrolidine type of prolyl oligopeptidase inhibitors the l-prolyl group was replaced by different 5-alkyl- l-prolyl groups, resulting in a series of N-acyl-5-alkyl- l-prolyl-pyrrolidines. Since N-amides of 5-alkyl- l-prolines are conformationally more rigid than those of l-pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2003-08, Vol.11 (17), p.3611-3619
Hauptverfasser: Wallén, Erik A.A., Christiaans, Johannes A.M., Saarinen, Taija J., Jarho, Elina M., Forsberg, Markus M., Venäläinen, Jarkko I., Männistö, Pekka T., Gynther, Jukka
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3619
container_issue 17
container_start_page 3611
container_title Bioorganic & medicinal chemistry
container_volume 11
creator Wallén, Erik A.A.
Christiaans, Johannes A.M.
Saarinen, Taija J.
Jarho, Elina M.
Forsberg, Markus M.
Venäläinen, Jarkko I.
Männistö, Pekka T.
Gynther, Jukka
description In the N-acyl- l-prolyl-pyrrolidine type of prolyl oligopeptidase inhibitors the l-prolyl group was replaced by different 5-alkyl- l-prolyl groups, resulting in a series of N-acyl-5-alkyl- l-prolyl-pyrrolidines. Since N-amides of 5-alkyl- l-prolines are conformationally more rigid than those of l-proline, the main objective was to make more rigid prolyl oligopeptidase inhibitors. In the series of compounds where the N-acyl group was a Boc group, the 5( R)- tert-butyl group increased the potency strongly. A similar effect was not observed for the 5( S)- tert-butyl group. In the series of compounds where the N-acyl group was a 4-phenylbutanoyl group, the 5( R)- tert-butyl, 5( R)-methyl and 5( S)-methyl groups did not have an effect on the potency [the 5( S)- tert-butyl group was not tested in this series]. As an additional effect, the 5- tert-butyl groups increased the log P of the compounds 1.5 log units, which might be beneficial when targeting the compounds to the brain. In the N-acyl- l-prolyl-pyrrolidine type of prolyl oligopeptidase inhibitors the l-prolyl group was replaced by different 5-alkyl- l-prolyl groups, resulting in a series of N-acyl-5-alkyl- l-prolyl-pyrrolidines.
doi_str_mv 10.1016/S0968-0896(03)00363-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73543674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089603003638</els_id><sourcerecordid>73543674</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-bf1f5dbd0b15da0943face13bc76d0a96b2756efe767fdeb60dbb28d9fa887b93</originalsourceid><addsrcrecordid>eNqFkE1v1DAQhi0EotvCTyjKBdQeDOM4ceITQqtCkSo4AGfjj3Hr1hsHO1tp_z1ud0WPnGY0embm1UPIKYP3DJj48AOkGCmMUpwBPwfggtPxGVmxTnSUc8mek9U_5Igcl3ILAG0n2UtyxFoJTIJYkd_rNPmUN3oJadIx7pocroNrvlFtd5H2VMe7WptI55xi7eZdrk1wYcLS6NLsx00dXacZ5yU4XbAJ000wYUm5vCIvvI4FXx_qCfn1-eLn-pJeff_ydf3pitqadaHGM98748Cw3mmQHffaIuPGDsKBlsK0Qy_Q4yAG79AIcMa0o5Nej-NgJD8h7_Z3a6A_WyyL2oRiMUY9YdoWNfC-42LoKtjvQZtTKRm9mnPY6LxTDNSDWvWoVj14U8DVo1o11r03hwdbs0H3tHVwWYG3B0AXq6PPerKhPHE9gBj6tnIf9xxWHfcBsyo24GTRhYx2US6F_0T5C_0NmHc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73543674</pqid></control><display><type>article</type><title>Conformationally rigid N-acyl-5-alkyl- l-prolyl-pyrrolidines as prolyl oligopeptidase inhibitors</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wallén, Erik A.A. ; Christiaans, Johannes A.M. ; Saarinen, Taija J. ; Jarho, Elina M. ; Forsberg, Markus M. ; Venäläinen, Jarkko I. ; Männistö, Pekka T. ; Gynther, Jukka</creator><creatorcontrib>Wallén, Erik A.A. ; Christiaans, Johannes A.M. ; Saarinen, Taija J. ; Jarho, Elina M. ; Forsberg, Markus M. ; Venäläinen, Jarkko I. ; Männistö, Pekka T. ; Gynther, Jukka</creatorcontrib><description>In the N-acyl- l-prolyl-pyrrolidine type of prolyl oligopeptidase inhibitors the l-prolyl group was replaced by different 5-alkyl- l-prolyl groups, resulting in a series of N-acyl-5-alkyl- l-prolyl-pyrrolidines. Since N-amides of 5-alkyl- l-prolines are conformationally more rigid than those of l-proline, the main objective was to make more rigid prolyl oligopeptidase inhibitors. In the series of compounds where the N-acyl group was a Boc group, the 5( R)- tert-butyl group increased the potency strongly. A similar effect was not observed for the 5( S)- tert-butyl group. In the series of compounds where the N-acyl group was a 4-phenylbutanoyl group, the 5( R)- tert-butyl, 5( R)-methyl and 5( S)-methyl groups did not have an effect on the potency [the 5( S)- tert-butyl group was not tested in this series]. As an additional effect, the 5- tert-butyl groups increased the log P of the compounds 1.5 log units, which might be beneficial when targeting the compounds to the brain. In the N-acyl- l-prolyl-pyrrolidine type of prolyl oligopeptidase inhibitors the l-prolyl group was replaced by different 5-alkyl- l-prolyl groups, resulting in a series of N-acyl-5-alkyl- l-prolyl-pyrrolidines.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/S0968-0896(03)00363-8</identifier><identifier>PMID: 12901906</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Animals ; Biological and medical sciences ; Brain - enzymology ; Humans ; Medical sciences ; Miscellaneous ; Molecular Conformation ; Neuropharmacology ; Pharmacology. Drug treatments ; Pyrrolidines - chemical synthesis ; Pyrrolidines - chemistry ; Pyrrolidines - pharmacology ; Serine Endopeptidases - chemistry ; Serine Endopeptidases - metabolism ; Serine Proteinase Inhibitors - chemical synthesis ; Serine Proteinase Inhibitors - chemistry ; Serine Proteinase Inhibitors - pharmacology ; Swine</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2003-08, Vol.11 (17), p.3611-3619</ispartof><rights>2003 Elsevier Ltd</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-bf1f5dbd0b15da0943face13bc76d0a96b2756efe767fdeb60dbb28d9fa887b93</citedby><cites>FETCH-LOGICAL-c391t-bf1f5dbd0b15da0943face13bc76d0a96b2756efe767fdeb60dbb28d9fa887b93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0968-0896(03)00363-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15006752$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12901906$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wallén, Erik A.A.</creatorcontrib><creatorcontrib>Christiaans, Johannes A.M.</creatorcontrib><creatorcontrib>Saarinen, Taija J.</creatorcontrib><creatorcontrib>Jarho, Elina M.</creatorcontrib><creatorcontrib>Forsberg, Markus M.</creatorcontrib><creatorcontrib>Venäläinen, Jarkko I.</creatorcontrib><creatorcontrib>Männistö, Pekka T.</creatorcontrib><creatorcontrib>Gynther, Jukka</creatorcontrib><title>Conformationally rigid N-acyl-5-alkyl- l-prolyl-pyrrolidines as prolyl oligopeptidase inhibitors</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>In the N-acyl- l-prolyl-pyrrolidine type of prolyl oligopeptidase inhibitors the l-prolyl group was replaced by different 5-alkyl- l-prolyl groups, resulting in a series of N-acyl-5-alkyl- l-prolyl-pyrrolidines. Since N-amides of 5-alkyl- l-prolines are conformationally more rigid than those of l-proline, the main objective was to make more rigid prolyl oligopeptidase inhibitors. In the series of compounds where the N-acyl group was a Boc group, the 5( R)- tert-butyl group increased the potency strongly. A similar effect was not observed for the 5( S)- tert-butyl group. In the series of compounds where the N-acyl group was a 4-phenylbutanoyl group, the 5( R)- tert-butyl, 5( R)-methyl and 5( S)-methyl groups did not have an effect on the potency [the 5( S)- tert-butyl group was not tested in this series]. As an additional effect, the 5- tert-butyl groups increased the log P of the compounds 1.5 log units, which might be beneficial when targeting the compounds to the brain. In the N-acyl- l-prolyl-pyrrolidine type of prolyl oligopeptidase inhibitors the l-prolyl group was replaced by different 5-alkyl- l-prolyl groups, resulting in a series of N-acyl-5-alkyl- l-prolyl-pyrrolidines.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Brain - enzymology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Molecular Conformation</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyrrolidines - chemical synthesis</subject><subject>Pyrrolidines - chemistry</subject><subject>Pyrrolidines - pharmacology</subject><subject>Serine Endopeptidases - chemistry</subject><subject>Serine Endopeptidases - metabolism</subject><subject>Serine Proteinase Inhibitors - chemical synthesis</subject><subject>Serine Proteinase Inhibitors - chemistry</subject><subject>Serine Proteinase Inhibitors - pharmacology</subject><subject>Swine</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1v1DAQhi0EotvCTyjKBdQeDOM4ceITQqtCkSo4AGfjj3Hr1hsHO1tp_z1ud0WPnGY0embm1UPIKYP3DJj48AOkGCmMUpwBPwfggtPxGVmxTnSUc8mek9U_5Igcl3ILAG0n2UtyxFoJTIJYkd_rNPmUN3oJadIx7pocroNrvlFtd5H2VMe7WptI55xi7eZdrk1wYcLS6NLsx00dXacZ5yU4XbAJ000wYUm5vCIvvI4FXx_qCfn1-eLn-pJeff_ydf3pitqadaHGM98748Cw3mmQHffaIuPGDsKBlsK0Qy_Q4yAG79AIcMa0o5Nej-NgJD8h7_Z3a6A_WyyL2oRiMUY9YdoWNfC-42LoKtjvQZtTKRm9mnPY6LxTDNSDWvWoVj14U8DVo1o11r03hwdbs0H3tHVwWYG3B0AXq6PPerKhPHE9gBj6tnIf9xxWHfcBsyo24GTRhYx2US6F_0T5C_0NmHc</recordid><startdate>20030815</startdate><enddate>20030815</enddate><creator>Wallén, Erik A.A.</creator><creator>Christiaans, Johannes A.M.</creator><creator>Saarinen, Taija J.</creator><creator>Jarho, Elina M.</creator><creator>Forsberg, Markus M.</creator><creator>Venäläinen, Jarkko I.</creator><creator>Männistö, Pekka T.</creator><creator>Gynther, Jukka</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030815</creationdate><title>Conformationally rigid N-acyl-5-alkyl- l-prolyl-pyrrolidines as prolyl oligopeptidase inhibitors</title><author>Wallén, Erik A.A. ; Christiaans, Johannes A.M. ; Saarinen, Taija J. ; Jarho, Elina M. ; Forsberg, Markus M. ; Venäläinen, Jarkko I. ; Männistö, Pekka T. ; Gynther, Jukka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-bf1f5dbd0b15da0943face13bc76d0a96b2756efe767fdeb60dbb28d9fa887b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Brain - enzymology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Molecular Conformation</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyrrolidines - chemical synthesis</topic><topic>Pyrrolidines - chemistry</topic><topic>Pyrrolidines - pharmacology</topic><topic>Serine Endopeptidases - chemistry</topic><topic>Serine Endopeptidases - metabolism</topic><topic>Serine Proteinase Inhibitors - chemical synthesis</topic><topic>Serine Proteinase Inhibitors - chemistry</topic><topic>Serine Proteinase Inhibitors - pharmacology</topic><topic>Swine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wallén, Erik A.A.</creatorcontrib><creatorcontrib>Christiaans, Johannes A.M.</creatorcontrib><creatorcontrib>Saarinen, Taija J.</creatorcontrib><creatorcontrib>Jarho, Elina M.</creatorcontrib><creatorcontrib>Forsberg, Markus M.</creatorcontrib><creatorcontrib>Venäläinen, Jarkko I.</creatorcontrib><creatorcontrib>Männistö, Pekka T.</creatorcontrib><creatorcontrib>Gynther, Jukka</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wallén, Erik A.A.</au><au>Christiaans, Johannes A.M.</au><au>Saarinen, Taija J.</au><au>Jarho, Elina M.</au><au>Forsberg, Markus M.</au><au>Venäläinen, Jarkko I.</au><au>Männistö, Pekka T.</au><au>Gynther, Jukka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Conformationally rigid N-acyl-5-alkyl- l-prolyl-pyrrolidines as prolyl oligopeptidase inhibitors</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2003-08-15</date><risdate>2003</risdate><volume>11</volume><issue>17</issue><spage>3611</spage><epage>3619</epage><pages>3611-3619</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>In the N-acyl- l-prolyl-pyrrolidine type of prolyl oligopeptidase inhibitors the l-prolyl group was replaced by different 5-alkyl- l-prolyl groups, resulting in a series of N-acyl-5-alkyl- l-prolyl-pyrrolidines. Since N-amides of 5-alkyl- l-prolines are conformationally more rigid than those of l-proline, the main objective was to make more rigid prolyl oligopeptidase inhibitors. In the series of compounds where the N-acyl group was a Boc group, the 5( R)- tert-butyl group increased the potency strongly. A similar effect was not observed for the 5( S)- tert-butyl group. In the series of compounds where the N-acyl group was a 4-phenylbutanoyl group, the 5( R)- tert-butyl, 5( R)-methyl and 5( S)-methyl groups did not have an effect on the potency [the 5( S)- tert-butyl group was not tested in this series]. As an additional effect, the 5- tert-butyl groups increased the log P of the compounds 1.5 log units, which might be beneficial when targeting the compounds to the brain. In the N-acyl- l-prolyl-pyrrolidine type of prolyl oligopeptidase inhibitors the l-prolyl group was replaced by different 5-alkyl- l-prolyl groups, resulting in a series of N-acyl-5-alkyl- l-prolyl-pyrrolidines.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>12901906</pmid><doi>10.1016/S0968-0896(03)00363-8</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0968-0896
ispartof Bioorganic & medicinal chemistry, 2003-08, Vol.11 (17), p.3611-3619
issn 0968-0896
1464-3391
language eng
recordid cdi_proquest_miscellaneous_73543674
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Biological and medical sciences
Brain - enzymology
Humans
Medical sciences
Miscellaneous
Molecular Conformation
Neuropharmacology
Pharmacology. Drug treatments
Pyrrolidines - chemical synthesis
Pyrrolidines - chemistry
Pyrrolidines - pharmacology
Serine Endopeptidases - chemistry
Serine Endopeptidases - metabolism
Serine Proteinase Inhibitors - chemical synthesis
Serine Proteinase Inhibitors - chemistry
Serine Proteinase Inhibitors - pharmacology
Swine
title Conformationally rigid N-acyl-5-alkyl- l-prolyl-pyrrolidines as prolyl oligopeptidase inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T01%3A09%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Conformationally%20rigid%20N-acyl-5-alkyl-%20l-prolyl-pyrrolidines%20as%20prolyl%20oligopeptidase%20inhibitors&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Wall%C3%A9n,%20Erik%20A.A.&rft.date=2003-08-15&rft.volume=11&rft.issue=17&rft.spage=3611&rft.epage=3619&rft.pages=3611-3619&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/S0968-0896(03)00363-8&rft_dat=%3Cproquest_cross%3E73543674%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73543674&rft_id=info:pmid/12901906&rft_els_id=S0968089603003638&rfr_iscdi=true